ANI Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ANIP and other ETFs, options, and stocks.

About ANIP

ANI Pharmaceuticals, Inc. is a bio-pharmaceutical company, which engages in the development, manufacture, and marketing of branded and generic prescription pharmaceuticals. It operates through the Generics, Established Brands, and Other, and Rare Disease segments. 

CEO
Nikhil Lalwani
CEONikhil Lalwani
Employees
897
Employees897
Headquarters
Baudette, Minnesota
HeadquartersBaudette, Minnesota
Founded
1996
Founded1996
Employees
897
Employees897

ANIP Key Statistics

Market cap
1.83B
Market cap1.83B
Price-Earnings ratio
50.15
Price-Earnings ratio50.15
Dividend yield
Dividend yield
Average volume
398.72K
Average volume398.72K
High today
$83.25
High today$83.25
Low today
$81.15
Low today$81.15
Open price
$82.17
Open price$82.17
Volume
399.48K
Volume399.48K
52 Week high
$99.50
52 Week high$99.50
52 Week low
$52.50
52 Week low$52.50

Stock Snapshot

ANI Pharmaceuticals(ANIP) stock is priced at $81.30, giving the company a market capitalization of 1.83B. It carries a P/E multiple of 50.15.

On 2025-12-08, ANI Pharmaceuticals(ANIP) stock moved within a range of $81.15 to $83.25. With shares now at $81.30, the stock is trading +0.2% above its intraday low and -2.3% below the session's peak.

Trading activity shows a volume of 399.48K, compared to an average daily volume of 398.72K.

Over the past 52 weeks, ANI Pharmaceuticals(ANIP) stock has traded between a high of $99.50 and a low of $52.50.

Over the past 52 weeks, ANI Pharmaceuticals(ANIP) stock has traded between a high of $99.50 and a low of $52.50.

ANIP News

Simply Wall St 4d
The Bull Case For ANI Pharmaceuticals Could Change Following Governance Shake-Up And FutureVision Launch – Learn Why

ANI Pharmaceuticals recently reshaped its leadership and governance, with Patrick D. Walsh stepping down as Chairman ahead of his 2026 Board retirement and Thom...

The Bull Case For ANI Pharmaceuticals Could Change Following Governance Shake-Up And FutureVision Launch – Learn Why

Analyst ratings

89%

of 9 ratings
Buy
88.9%
Hold
11.1%
Sell
0%

People also own

Based on the portfolios of people who own ANIP. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.